Inflammatory bowel disease and thrombosis.

Area of Science:

• Gastroenterology
• Hematology
• Internal Medicine

Background:

• Inflammatory Bowel Disease (IBD) encompasses chronic gastrointestinal inflammatory conditions.
• Extraintestinal manifestations are common in IBD patients.
• IBD is associated with an increased risk of thrombotic events, similar to other inflammatory conditions.

Purpose of the Study:

• To review the positive relationship between Inflammatory Bowel Disease and thrombotic events.
• To discuss the multidimensional pathogenesis of thrombotic tendency in IBD.
• To outline appropriate treatment and management for IBD patients at risk of thrombosis.

Main Methods:

• Literature review focusing on IBD and thrombotic events.
• Analysis of contributing factors to hypercoagulability in IBD.
• Synthesis of current understanding on managing thrombosis risk in IBD.

Main Results:

• The pathogenesis of thrombotic tendency in IBD is multifactorial.
• Factors include reduced natural anticoagulants, prothrombotic inflammatory mediators, sedentary lifestyle, steroid use, surgery, and catheterization.
• A clear link exists between IBD and an increased propensity for blood clot formation.

Conclusions:

• IBD patients face a significant risk of thrombotic events.
• Understanding the contributing factors is crucial for risk assessment.
• Proactive management and treatment are essential for at-risk IBD patients to prevent thrombotic complications.